Xiao Min Schebye
About Xiao Min Schebye
Xiao Min Schebye is the Associate Director of Immuno-Oncology Discovery at Bristol-Myers Squibb, with a medical background and scientific expertise in oncology and immunology.
Current Title and Role
Xiao Min Schebye serves as Associate Director, Immuno Oncology Discovery at Bristol-Myers Squibb. She works in the San Francisco Bay Area, focusing on overseeing antibody discovery programs aimed at cancer immunotherapy. Her responsibilities include managing programs with two antibodies currently in clinical testing, reflecting her expertise in translating basic scientific discoveries into actionable drug therapies.
Previous Positions
Xiao Min Schebye has an extensive background in various high-level scientific roles. From 2012 to 2014, she was the Senior Fellow and Head of Immunology at ChemPartner in Shanghai City, China. Before that, she spent a decade at Merck as a Principal Scientist from 2001 to 2011. Additionally, she held the position of Senior Scientist at Incyte from 1999 to 2001, working in the San Francisco Bay Area.
Educational Background
Xiao Min Schebye boasts an impressive educational background. She completed her postdoctoral fellowship at Stanford University. She earned her PhD in Biology from the University of Wisconsin-Madison. Prior to that, she achieved her MD in Medicine from Shanghai Jiao Tong University, combining a deep understanding of medicine with scientific expertise.
Experience in Biotech and Pharma
With 18 years of experience in the biotech and pharmaceutical industries, Xiao Min Schebye has demonstrated a strong capability in immuno-oncology. She has effectively translated basic scientific discoveries into novel drug therapies, with a focus on cancer immunotherapy. Her expertise as a cell biologist further enhances her ability to contribute to innovative research and development in her field.
Specialization in Oncology and Immunology
Xiao Min Schebye specializes in oncology and immunology, leveraging her combined medical and scientific background. Her role as Associate Director at Bristol-Myers Squibb involves overseeing multiple antibody discovery programs aimed at treating cancer through immunotherapy. Her background enables her to adeptly manage and drive forward significant research initiatives in this specialized area of medicine.